Therefore, accurately predicting pathological response to NACI before treatment is highly significant for enhancing personalized treatment and clinical decision-making in patients with advanced gastric cancer.
← all excerpts
Predicting response to neoadjuvant chemotherapy combined with immunotherapy in gastric cancer based on habitat imaging and peritumoral radiomics: a two-center study.
1
—
—